José María Teijón Rivera-rekin lankidetzan egindako argitalpenak (8)

2019

  1. Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs

    International Journal of Pharmaceutics, Vol. 554, pp. 337-351

2016

  1. The role of anionic polysaccharides in the preparation of nanomedicines with anticancer applications

    Current Pharmaceutical Design, Vol. 22, Núm. 22, pp. 3364-3379

2015

  1. Biocompatibility evaluation of pH and glutathione-responsive nanohydrogels after intravenous administration

    Colloids and Surfaces B: Biointerfaces, Vol. 136, pp. 222-231

  2. Improved antitumor effect of paclitaxel administered in vivo as pH and glutathione-sensitive nanohydrogels

    International Journal of Pharmaceutics, Vol. 492, Núm. 1-2, pp. 10-19

2014

  1. Bioresponsive nanohydrogels based on HEAA and NIPA for poorly soluble drugs delivery

    International Journal of Pharmaceutics, Vol. 470, Núm. 1-2, pp. 107-119

  2. PH and glutathion-responsive hydrogel for localized delivery of paclitaxel

    Colloids and Surfaces B: Biointerfaces, Vol. 116, pp. 247-256

2012

  1. Synthesis and in vitro biological evaluation as antitumour drug carriers of folate-targeted N-isopropylacrylamide-based nanohydrogels

    Polymer International, Vol. 61, Núm. 7, pp. 1202-1212

  2. Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: Characterization and in vitro evaluation as sustained release systems

    Journal of Microencapsulation, Vol. 29, Núm. 4, pp. 309-322